Lymphocyte Gene Expression Signatures from Patients and Mouse Models of Hereditary Hemochromatosis Reveal a Function of HFE as a Negative Regulator of CD8+ T-Lymphocyte Activation and Differentiation In Vivo
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Abnormally low CD8+ T-lymphocyte numbers is characteristic of some patients with hereditary hemochromatosis (HH), a MHC-linked disorder of iron overload. Both environmental and genetic components are known to influence CD8+ T-lymphocyte homeostasis but the role of the HH associated protein HFE is still insufficiently understood. Genome-wide expression profiling was performed in peripheral blood CD8+ T lymphocytes from HH patients selected according to CD8+ T-lymphocyte numbers and from Hfe-/- mice maintained either under normal or high iron diet conditions. In addition, T-lymphocyte apoptosis and cell cycle progression were analyzed by flow cytometry in HH patients. HH patients with low CD8+ T-lymphocyte numbers show a differential expression of genes related to lymphocyte differentiation and maturation namely CCR7, LEF1, ACTN1, NAA50, P2RY8 and FOSL2, whose expression correlates with the relative proportions of naïve, central and effector memory subsets. In addition, expression levels of LEF1 and P2RY8 in memory cells as well as the proportions of CD8+ T cells in G2/M cell cycle phase are significantly different in HH patients compared to controls. Hfe-/- mice do not show alterations in CD8+ T-lymphocyte numbers but differential gene response patterns. We found an increased expression of S100a8 and S100a9 that is most pronounced in high iron diet conditions. Similarly, CD8+ T lymphocytes from HH patients display higher S100a9 expression both at the mRNA and protein level. Altogether, our results support a role for HFE as a negative regulator of CD8+ T-lymphocyte activation. While the activation markers S100a8 and S100a9 are strongly increased in CD8+ T cells from both, Hfe-/- mice and HH patients, a differential profile of genes related to differentiation/maturation of CD8+ T memory cells is evident in HH patients only. This supports the notion that HFE contributes, at least in part, to the generation of low peripheral blood CD8+ T lymphocytes in HH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, IO due to HH results in low numbers of CD8 + T cells and a divergent T cell receptor (TCR) repertoire in this population, possibly because IO continuously sustains the activation and subsequent exhaustion of CD8 + T cells which is associated with their reduced cytotoxicity (Arosa et al., 1997;Cardoso et al., 2001;Costa et al., 2015;Cruz et al., 2006).”
From Iron in infection and immunity (2020) · cites this paper as Costa et al., 2015
Experimental — accuracy not yet measuredIn the citing paper
“while patients suffering from hereditary hemochromatosis (HH) have apparently normal CD4+ and reduced CD8+ numbers, with the latter displaying a more “effector” phenotype, suggesting again that increased intracellular iron availability may have hyper-proliferative effects in T cells, although this may well-depend on which oxidation form of Fe is available (Costa et al., 2015).”
From The Role of Iron Regulation in Immunometabolism and Immune-Related Disease (2019) · cites this paper as Costa et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664 · cited 1×
“The conformational change introduced by the C282Y mutation impairs the association of HFE with β(2)-microglobulin and consequently its expression at the cell surface [3].”
BackgroundHeterogeneity of CD4+ memory T cells: Functional modules for tailored immunity
Sallusto, F., & Lanzavecchia, A. (2009) · European Journal of Immunology · doi:10.1002/eji.200939722 · Cited by 348
MHC class Ib molecules bridge innate and acquired immunity
Rodgers, J. R., & Cook, R. G. (2005) · Nature Reviews Immunology · doi:10.1038/nri1635 · Cited by 323
The discovery of the new haemochromatosis gene
Brissot, P. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00142-9 · Cited by 313
Loser, K., Vogl, T., Voskort, M., Lueken, A., Kupas, V., Nacken, W., Klenner, L., Kuhn, A., Foell, D., Sorokin, L., et al. (2010) · Nature Medicine · doi:10.1038/nm.2150 · Cited by 296
Cutting Edge: Resident Memory CD8 T Cells Occupy Frontline Niches in Secondary Lymphoid Organs
Schenkel, J. M., Fraser, K. A., & Masopust, D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400003 · Cited by 215
Willinger, T., Freeman, T., Herbert, M., Hasegawa, H., McMichael, A. J., & Callan, M. F. C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1439 · Cited by 200
D’Alessio, F., Hentze, M. W., & Muckenthaler, M. U. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.015 · Cited by 200 · cited 1×
“As an integral part of a membrane-associated protein complex in hepatocytes, HFE is involved in the regulation of hepcidin, a hormone that controls systemic iron levels [4].”
BackgroundSelf-citationHuman memory T cells from the bone marrow are resting and maintain long-lasting systemic memory
Okhrimenko, A., Grün, J. R., Westendorf, K., Fang, Z., Reinke, S., von Roth, P., Wassilew, G., Kühl, A. A., Kudernatsch, R., Demski, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318731111 · Cited by 188
Simon, M., Le Mignon, L., Fauchet, R., Yaouanq, J., David, V., Edan, G., & Bourel, M. (1987) · Europe PMC (PubMed Central) · Cited by 181
IRON METABOLISM. IRON STORES IN MAN AS MEASURED BY PHLEBOTOMY 1
Haskins, D., Stevens, A. R., Finch, S., & Finch, C. A. (1952) · Journal of Clinical Investigation · doi:10.1172/jci102639 · Cited by 175
Iron overload in β2-microglobulin-deficient mice
DESOUSA, M., REIMAO, R., LACERDA, R., HUGO, P., KAUFMANN, S., & PORTO, G. (1994) · Immunology Letters · doi:10.1016/0165-2478(94)90094-9 · Cited by 172
Self-citationExperimental hemochromatosis due to MHC class I HFE deficiency: Immune status and iron metabolism
Bahram, S., Gilfillan, S., Kühn, L. C., Moret, R., Schulze, J. B., Lebeau, A., & Schümann, K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13312 · Cited by 168
Porto, G. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i35.4707 · Cited by 140 · cited 1×
“Abnormalities in the pool of CD8, but not CD4, T lymphocytes have been consistently reported in HH patients [5].”
BackgroundSelf-citationLipocalin-2 ameliorates granulocyte functionality
Schroll, A., Eller, K., Feistritzer, C., Nairz, M., Sonnweber, T., Moser, P. A., Rosenkranz, A. R., Theurl, I., & Weiss, G. (2012) · European Journal of Immunology · doi:10.1002/eji.201142351 · Cited by 135
Quantification of Multiple Gene Expression in Individual Cells
Peixoto, A., Monteiro, M., Rocha, B., & Veiga-Fernandes, H. (2004) · Genome Research · doi:10.1101/gr.2890204 · Cited by 131
Cesaro, A., Anceriz, N., Plante, A., Pagé, N., Tardif, M. R., & Tessier, P. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045478 · Cited by 115
Identification of RELMγ, a novel resistin-like molecule with a distinct expression pattern☆
Gerstmayer, B., Küsters, D., Gebel, S., Müller, T., Miert, E. V., Hofmann, K., & Bosio, A. (2003) · Genomics · doi:10.1016/s0888-7543(03)00070-3 · Cited by 113
Starheim, K. K., Gromyko, D., Evjenth, R., Ryningen, A., Varhaug, J. E., Lillehaug, J. R., & Arnesen, T. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01909-08 · Cited by 113
Peixoto, A., Evaristo, C., Munitić, I., Monteiro, M., Charbit, A., Rocha, B., & Veiga‐Fernandes, H. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062349 · Cited by 92
Hemochromatosis : genetics, pathophysiology, diagnosis, and treatment
Barton, J. C., & Edwards, C. Q. (2000) · Cambridge University Press eBooks · Cited by 86
de Sousa, M. A. B., Smithyman, A. M., & Tan, C. (1978) · PubMed · Cited by 81
Adrian, K., Bernhard, M. K., Breitinger, H., & Ogilvie, A. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00094-4 · Cited by 80
Coordinate control of cytoskeletal remodeling and calcium mobilization during T‐cell activation
Babich, A., & Burkhardt, J. K. (2013) · Immunological Reviews · doi:10.1111/imr.12123 · Cited by 79
Relative Impact of Hla Phenotype and Cd4–Cd8 Ratios on the Clinical Expression of Hemochromatosis
Porto, G., Vicente, C., Teixeira, M. A., Martins, O., Cabeda, J. M., Lacerda, R., Gonçalves, C., Fraga, J., Macedo, G., Silva, B. M., et al. (1997) · Hepatology · doi:10.1002/hep.510250223 · Cited by 72
Self-citationAnomalies of the CD8+ T cell pool in haemochromatosis: HLA-A3-linked expansions of CD8+CD28- T cells
AROSA, F. A., OLIVEIRA, L., PORTO, G., DA SILVA, B. M., KRUIJER, W., VELTMAN, J., & DE SOUSA, M. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1997.d01-967.x · Cited by 70 · cited 1×
“Although decreased CD8-associated p56lck activity [11] and diminished cytotoxic activity [12] have been reported, other studies suggested a more activated profile of these cells namely a relative expansion of CD8CD28 T-cell populations, a high percentage of CD8HLA-DR cells and an increased production of IL-4 and IL-10…”
ResultSelf-citationPorto, G., Reimαo, R., Gonçalves, C., Vicente, C., Justiça, B., & de Sousa, M. (1994) · European Journal of Haematology · doi:10.1111/j.1600-0609.1994.tb00097.x · Cited by 68
Self-citationKhammanivong, A., Wang, C., Sorenson, B. S., Ross, K. F., & Herzberg, M. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069395 · Cited by 59
Hemochromatosis: Genetics, Pathophysiology, Diagnosis, and Treatment
Felitti, V. J. (2000) · JAMA · doi:10.1001/jama.284.12.1581 · Cited by 58
Effects of iron loading on muscle: genome-wide mRNA expression profiling in the mouse
Rodríguez, A., Hilvo, M., Kytömäki, L., Fleming, R. E., Britton, R. S., Bacon, B. R., & Parkkila, S. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-379 · Cited by 52
Iron, Iron‐binding Proteins and Immune System Cellsa
De Sousa, M., Breedvelt, F., Dynesius‐Trentham, R., Trentham, D., & Lum, J. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb55515.x · Cited by 48
Physiological implications of NTBI uptake by T lymphocytes
Pinto, J. P., Arezes, J., Dias, V., Oliveira, S., Vieira, I., Costa, M., Vos, M., Carlsson, A., Rikers, Y., Rangel, M., et al. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00024 · Cited by 47
Self-citationAROSA, F. A., DA SILVA, A. J., GODINHO, I. M., TER STEEGE, J. C. A., PORTO, G., RUDD, C. E., & DE SOUSA, M. (1994) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1994.tb03396.x · Cited by 45
Self-citationDhanji, S., Teh, S.-J., Oble, D. A., Priatel, J. J., & Teh, H. (2004) · Blood · doi:10.1182/blood-2004-01-0150 · Cited by 44
Iron and Lymphocytes: Reciprocal Regulatory Interactions1
de Sousa, M. A. B., Reim�o, R., Porto, G. A., Grady, R. W., Hilgartner, M. W., & Giardina, P. J. (2015) · Current studies in hematology and blood transfusion · doi:10.1159/000419357 · Cited by 44
Self-citationArezes, J., Costa, M., Vieira, I., Dias, V., Kong, X. L., Fernandes, R., Vos, M., Carlsson, A., Rikers, Y., Porto, G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079870 · Cited by 43
Self-citationMonteiro, M., Evaristo, C., Legrand, A., Nicoletti, A., & Rocha, B. (2007) · Blood · doi:10.1182/blood-2006-06-027060 · Cited by 42
Cruz, E., Melo, G., Lacerda, R., Almeida, S., & Porto, G. (2006) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2006.04.004 · Cited by 41
Self-citationHepatic damage in C282Y homozygotes relates to low numbers of CD8+ cells in the liver lobuli
Cardoso, E. M., Hagen, K., de Sousa, M. A. B., & Hultcrantz, R. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00744.x · Cited by 40
Lima, M., Teixeira, M. D. A., Fonseca, S., Gonçalves, C., Guerra, M., Queirós, M. L., Santos, A. H., Coutinho, A., Pinho, L., Marques, L., et al. (2000) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2000.0342 · Cited by 39
Self-citationCruz, E., Vieira, J., Almeida, S., Lacerda, R., Gartner, A., Cardoso, C. S., Alves, H., & Porto, G. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-16 · Cited by 37
Self-citationReimão, R., Porto, G., & de Sousa, M. A. B. (1991) · PubMed · Cited by 35
Self-citationFerritin—a mediator of apoptosis?
Bresgen, N., Ohlenschläger, I., Fiedler, B., Wacht, N., Zach, S., Dunkelmann, B., Arosio, P., Kuffner, E., Lottspeich, F., & Eckl, P. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21009 · Cited by 32
Increased hepatic iron in mice lacking classical MHC class I molecules
Cardoso, E. M., Macedo, M. G., Rohrlich, P., Ribeiro, E., Silva, M. T., Lemonnier, F. A., & de Sousa, M. (2002) · Blood · doi:10.1182/blood-2002-05-1565 · Cited by 28
Self-citationMacedo, M. F., Porto, G., Costa, M., Vieira, C. P., Rocha, B., & Cruz, E. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.04066.x · Cited by 28
Self-citationExpression and function of FRA2/JUND in cutaneous T-cell lymphomas.
Nakayama, T., Higuchi, T., Oiso, N., Kawada, A., & Yoshie, O. (2012) · PubMed · Cited by 28
Cruz, E., Whittington, C., Krikler, S. H., Mascarenhas, C., Lacerda, R., Vieira, J., & Porto, G. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-97 · Cited by 27
Self-citationPeripheral lymphocytes and intracellular cytokines in C282Y homozygous hemochromatosis patients
Fabio, G., Zarantonello, M., Mocellin, C., Bonara, P., Corengia, C., Fargion, S. R., & Fiorelli, G. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00276-3 · Cited by 26
Variation of hemochromatosis prevalence and genotype in national groups
Porto, G., & de Sousa, M. A. B. (2000) · Cambridge University Press eBooks · doi:10.1017/cbo9780511666476.006 · Cited by 25
Self-citationSignal regulators in FcR-mediated activation of leukocytes?
Mina‐Osorio, P., & Ortega, E. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.08.008 · Cited by 23
The WT hemochromatosis protein HFE inhibits CD8+ T‐lymphocyte activation
Reuben, A., Phénix, M., Santos, M. M., & Lapointe, R. (2014) · European Journal of Immunology · doi:10.1002/eji.201343955 · Cited by 21
Lim, S. C., Ju, J. Y., Chi, S. Y., Ban, H., Kwon, Y. S., Oh, I., Kim, K. S., Kim, Y. I., & Kim, Y. C. (2011) · Yonsei Medical Journal · doi:10.3349/ymj.2011.52.4.581 · Cited by 20
Gréen, A., Sarg, B., Gréen, H., Lönn, A., Lindner, H. H., & Rundquist, I. (2011) · Epigenetics & Chromatin · doi:10.1186/1756-8935-4-15 · Cited by 18
Costa, M., Cruz, E., Barton, J. C., Thorstensen, K., Morais, S. A., da Silva, B. M., Pinto, J. P., Vieira, C. P., Vieira, J., Acton, R. T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079990 · Cited by 16
Self-citationRough‐Form Lipopolysaccharide Increases Apoptosis in Human CD4+ and CD8+ T Lymphocytes
Nielsen, J. S. A., Larsson, A. O., Ledet, T., Turina, M., Tønnesen, E., & Krog, J. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02613.x · Cited by 14
Iron-induced Damage in Corpus Striatal Cells of Neonatal Rats: Attenuation by Folic Acid
Eldien, H. M. S., Mohamed, A., & Hussein, M. R. (2012) · Ultrastructural Pathology · doi:10.3109/01913123.2011.630125 · Cited by 7
Porto, B., Vieira, R. D. A., & Porto, G. (2008) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2008.11.016 · Cited by 6
Self-citation
Cited by
Iron in infection and immunity
Nairz, M., & Weiss, G. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100864 · Cited by 359
The Role of Iron Regulation in Immunometabolism and Immune-Related Disease
Cronin, S. J. F., Woolf, C. J., Weiss, G., & Penninger, J. M. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00116 · Cited by 299
Crux, N. B., & Elahi, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00832 · Cited by 239
Iron Metabolism in Cancer Progression
Forciniti, S., Greco, L., Grizzi, F., Malesci, A., & Laghi, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062257 · Cited by 116
Revisiting hemochromatosis: genetic vs. phenotypic manifestations
Anderson, G. J., & Bardou‐Jacquet, E. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5512 · Cited by 70
Metadata
- Authors
- Costa, M., Cruz, E., Oliveira, S., Benes, V., Ivacevic, T., Silva, M. J., Vieira, I., Dias, F., Fonseca, S., Gonçalves, M., Lima, M., Leitão, C., Muckenthaler, M. U., Pinto, J., & Porto, G.
- Affiliations
- Universidade do Porto (PT)
- European Molecular Biology Laboratory (DE)
- Hospital de Santo António (PT)
- Heidelberg University (DE)
- Corresponding author
- Porto, Graça
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-04-16
- Volume
- 10
- Issue
- 4
- Pages
- e0124246
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4399836
- OpenAlex
- W2010139783
- Cited by
- 32
- References
- 57
- Citations by year
- 2026: 1 · 2025: 4 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 2 · 2017: 3 · 2016: 4 · 2015: 1
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- Programa Operacional Temático Factores de Competitividade (FCOMP-01-0124-FEDER-008447)
- Fundação para a Ciência e a Tecnologia (COMPETE, SFRH/BD/69186/2010, NORTE-07-0124-FEDER-000003, FCOMP-01-0124-FEDER, /2009)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- hereditary hemochromatosis, HFE gene, CD8+ T cells, T cell activation, T cell differentiation, memory T cells, S100A8, S100A9, iron overload, Hfe knockout mice, T cell apoptosis, cell cycle, gene expression profiling, CCR7, LEF1, FOSL2, ACTN1
- MeSH terms
- Hemochromatosis Protein, Animals, Cell Differentiation, Disease Models, Animal, Female, Hemochromatosis, Humans, Lymphocyte Activation, Lymphocytes, Membrane Proteins, Mice, Inbred C57BL, Histocompatibility Antigens Class I, Apoptosis, Mice, Knockout, CD8-Positive T-Lymphocytes, Genetic Diseases, Inborn, Cell Cycle Checkpoints, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.